Drug Use clinical trials at UCLA
5 in progress, 3 open to eligible people
Age-dependent Effects of Smoked and Oral Delta-9-THC
open to eligible people ages 18-65
This study will assess the age-dependent effects of smoked and oral THC on abuse liability, intoxication, analgesia and impairment as a function of age.
Los Angeles, California
Oral THC and CBD in Men and Women
open to eligible people ages 21-55
The purpose of this study is to determine the pharmacokinetics and pharmacodynamics of oral delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and to evaluate detection of recently smoked THC in oral fluid.
Los Angeles, California
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
open to eligible people ages 21-55
The purpose of this research is to assess the impact of CBD on the effects of THC.
Los Angeles, California
AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)
Sorry, in progress, not accepting new patients
This study will assess the analgesic, appetite-stimulating, and subjective effects of cannabigerol (CBG) alone and in combination with THC.
Los Angeles, California
Analgesic and Subjective Effects of Terpenes
Sorry, in progress, not accepting new patients
The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.
Los Angeles, California
Our lead scientists for Drug Use research studies include Ziva Cooper, PhD.
Last updated: